Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumorsAustin Gurney, Timothy Hoey, Fumiko Axelrod et al.|Proceedings of the National Academy of Sciences|2012Cited by 630
WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell deathMarcus Fischer, Timothy Hoey, James Evans et al.|Science Advances|2017Cited by 156
Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer TypesCécile Chartier, Austin Gurney, Janak Raval et al.|Cancer Research|2016Cited by 115
Abstract 207: Dual targeting of DLL4 and VEGF signaling by a novel bispecific antibody inhibits tumor growth and reduces cancer stem cell frequencyWan-Ching Yen, Timothy Hoey, Fumiko Axelrod et al.|Cancer Research|2014Cited by 1
Abstract 4367: Discovery and evaluation of pharmacodynamic and predictive biomarkers for anti-RSPO3, a treatment that reduces tumor growth and cancer stem cell frequency in patient derived xenograft tumor modelsFiore Cattaruzza, Ann M. Kapoun, Pete Yeung et al.|Cancer Research|2015Cited by 1